Catenin Beta-1 (CTNNB1) Gene Mutation: Clinical Trials

1 trial for Catenin Beta-1 (CTNNB1) Gene Mutation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Catenin Beta-1 (CTNNB1) Gene Mutation: new trials by email Literature Review of Catenin Beta-1 (CTNNB1) Gene Mutation trials Research Report on Catenin Beta-1 (CTNNB1) Gene Mutation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
Tegavivint - Metastatic Colorectal Carcinoma (mCRC), Colorectal Cancer (CRC)
Phase 1 / Phase 2RecruitingHonorHealth Research Institute1262026-02-172026-03-11

Narrower conditions

Adenomatous Polyposis Coli (1)  ·  Colorectal Neoplasms (1)

Broader conditions

Adenoma (1)  ·  Adenomatous Polyps (1)  ·  Colonic Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Genetic Diseases, Inborn (1)  ·  Intestinal Diseases (1)  ·  Intestinal Neoplasms (1)  ·  Intestinal Polyposis (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)

Sponsors

HonorHealth Research Institute (1)

Countries

United States (1)